ÂÜÀòÂÒÂ×

Zaneta Odrowaz is currently the Chief Business Officer at Attovia Therapeutics, after serving as VP Company Creation at Frazier Life Sciences. Prior to that, Zaneta Odrowaz held positions such as Senior Director Corporate Development at Amunix Pharmaceuticals and Chief Of Staff at Philips Neuro. With a background in gene expression and biotechnology, Zaneta Odrowaz has also worked as an Engagement Manager at McKinsey & Company and conducted research as a Postdoctoral Fellow at Stanford University, focusing on brain function, inflammation, and neurodegenerative diseases.